Core Cap Advisors, LLC Prothena Corp Public LTD CO Transaction History
Core Cap Advisors, LLC
- $2.64 Billion
- Q3 2025
A detailed history of Core Cap Advisors, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Core Cap Advisors, LLC holds 23 shares of PRTA stock, worth $231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$231
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRTA
# of Institutions
216Shares Held
33.7MCall Options Held
879KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$38.9 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$34 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$22.5 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$20.7 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$12.8 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $473M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...